Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
- 21 April 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 9 (7) , 1237-1248
Abstract
(2008). Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opinion on Pharmacotherapy: Vol. 9, No. 7, pp. 1237-1248. doi: 10.1517/14656566.9.7.1237Keywords
This publication has 50 references indexed in Scilit:
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled studyClinical Therapeutics, 2007
- Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2007
- Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?The American Journal of Cardiology, 2007
- Combination Therapy with Statins and Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisProceedings of the National Academy of Sciences, 2006
- Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responsesBritish Journal of Nutrition, 2002
- Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patencyThe American Journal of Cardiology, 1996